Atypical Teratoid Rhabdoid Tumor drugs in development, 2024

GlobalData tracks 18 drugs in development for Atypical Teratoid Rhabdoid Tumor by 16 companies/universities/institutes. The top development phase for Atypical Teratoid Rhabdoid Tumor is preclinical, with six drugs in that stage.

Updated: AstraZeneca says there’s ‘very limited’ impact on Farxiga after US drug pricing negotiations

AstraZeneca has concluded its price negotiations with the IRA for its blockbuster drug Farxiga, in the latest update for pharma companies undergoing the process. …

July 26, 2024

Lipocine’s weight loss drug shows early signs of keeping muscle mass in Ph2

Although Lipocine’s candidate may have delivered “modest” weight loss results, the company nonetheless touted its ability to preserve muscle mass in a mid-stage trial. It

April 12, 2024

Lincata Integrates with Epic’s MyChart Bedside in Epic Toolbox

What You Should Know: – Lincata, a provider of in-room connectivity solutions for healthcare launches LincTV, a groundbreaking device that transforms standard hospital televisions into

February 15, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.